Cargando…

Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus

BACKGROUND: Platelet-derived microparticles (PDMP), selectins, and adiponectin play an important role in the development of atherosclerosis in diabetes. Miglitol has been shown to have a beneficial effect on postprandial hyperglycemia in diabetic patients. However, its influence on platelet activati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomura, Shosaku, Omoto, Seitaro, Yokoi, Takashi, Fujita, Shinya, Ozasa, Ryotaro, Eguchi, Noritaka, Shouzu, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150178/ https://www.ncbi.nlm.nih.gov/pubmed/21845063 http://dx.doi.org/10.2147/IJGM.S22115

Ejemplares similares

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
por: Omoto, Seitaro, et al.
Publicado: (2015)

Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
por: Okuda, Yoshinori, et al.
Publicado: (2016)

Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricema
por: Nishizawa, Tohru, et al.
Publicado: (2015)

Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus
por: Nomura, Shosaku, et al.
Publicado: (2023)

Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)
por: Nomura, Shosaku, et al.
Publicado: (2018)

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients
por: Nomura, Shosaku, et al.
Publicado: (2012)

Platelet-Derived Microparticles are an Important Biomarker in Patients with Cancer-Associated Thrombosis
por: Yamanaka, Yuta, et al.
Publicado: (2019)

Antiplatelet antibody may cause delayed transfusion-related acute lung injury
por: Torii, Yoshitaro, et al.
Publicado: (2011)

Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients
por: Kubo, Sayaka, et al.
Publicado: (2010)

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin
por: Falati, Shahrokh, et al.
Publicado: (2003)

Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation
por: Ozasa, Ryotaro, et al.
Publicado: (2012)

Microparticles as Biomarkers of Blood Coagulation in Cancer
por: Nomura, Shosaku, et al.
Publicado: (2015)

Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation
por: Nomura, Shosaku, et al.
Publicado: (2023)

Additive Effects of Miglitol and Anagliptin on Insulin-Treated Type 2 Diabetes Mellitus: A Case Study
por: Kishimoto, Miyako, et al.
Publicado: (2014)

Microparticles and a P-Selectin-Mediated Pathway of Blood Coagulation
por: Celi, Alessandro, et al.
Publicado: (2004)

Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β(1), and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia
por: Nomura, Shosaku, et al.
Publicado: (2018)

Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients
por: Sawai, Yusuke, et al.
Publicado: (2020)

Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation
por: Lau, Yee Cheng, et al.
Publicado: (2016)

Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas
por: Hsieh, Sheng-Hwu, et al.
Publicado: (2010)

Stability-Indicating RP-HPLC Method for Estimation of Miglitol in Bulk and Tablets
por: Shrivastava, B., et al.
Publicado: (2010)

Effect of the Addition of Sitagliptin and Miglitol on Insulin-Treated Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2012)

Review: Miglitol has potential as a therapeutic drug against obesity
por: Sugimoto, Satoru, et al.
Publicado: (2015)

Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Incretin Kinetics Before and After Miglitol in Japanese Patients With Late Dumping Syndrome
por: Amagai, Mari, et al.
Publicado: (2017)

E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis
por: Ma, Shuangtao, et al.
Publicado: (2016)

Kinetic Determination of Acarbose and Miglitol in Bulk and Pharmaceutical Formulations Using Alkaline Potassium Permanganate
por: Ibrahim, F. A., et al.
Publicado: (2007)

Genetic analysis of HLA, NA and HPA typing in type 2 diabetes and ASO
por: Nomura, S, et al.
Publicado: (2006)

Development and Validation of Miglitol and Its Impurities by RP-HPLC and Characterization Using Mass Spectrometry Techniques
por: Balakumaran, Kesavan, et al.
Publicado: (2016)

Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model
por: Kishida, Yumi, et al.
Publicado: (2017)

Plasma platelet-derived microparticles to platelet count ratio as a marker of mortality in critically ill patients
por: Ohuchi, M, et al.
Publicado: (2014)

Polyphenols: Modulators of Platelet Function and Platelet Microparticle Generation?
por: Ed Nignpense, Borkwei, et al.
Publicado: (2019)

P-selectin-mediated platelet adhesion promotes tumor growth
por: Qi, Cuiling, et al.
Publicado: (2015)

Platelet Microparticle Controversial Role in Cancer
por: Nazari, Mahnaz, et al.
Publicado: (2021)

Platelet-Derived Microparticles and Autoimmune Diseases
por: Li, Xiaoshuai, et al.
Publicado: (2023)

Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia
por: Kitano, Daisuke, et al.
Publicado: (2013)

Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion
por: Lee, Eun Young, et al.
Publicado: (2015)

Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial
por: Iijima, Takahiro, et al.
Publicado: (2020)

Lipid profile of platelets and platelet-derived microparticles in ovarian cancer
por: Hu, Qianghua, et al.
Publicado: (2016)

Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo
por: Thomas, Grace M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6hm0c7u0r78sne48gfbb2traqq